about
Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamagePharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC-MS/MS): application to a pilot study of obese women undergoing cesarean delivery.Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation.Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids.Absolute Oral Bioavailability of Creatine Monohydrate in Rats: Debunking a Myth.Antimicrobial Prophylaxis for Patients Undergoing Cardiac Surgery: Intraoperative Cefazolin Concentrations and Sternal Wound InfectionsThe Antioxidant Activity of Recombinant Rat Hepatic Fatty Acid Binding Protein T94A VariantHDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylasesSelective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying EnzymesValidation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors
P50
Q33838894-2A8B6B0F-2D0C-4E98-81F4-E5806EB8E0DBQ38618573-9111501B-A7DF-4320-8BB5-D8582DDFE0ACQ38833038-DC0FD683-FD59-4700-8777-03233C746A16Q47297439-E0B3634B-D1FC-46A5-B3D4-3EF45848DCDBQ47404179-C3F69F91-D319-4C80-8AAA-54C98324A50CQ47431443-870CCF49-401D-400B-BB56-0E703EA84298Q47616504-A1014358-4ECF-4307-A6A3-518C99A2DD3CQ48204217-F6C3870B-1399-4070-8A8F-F94E19F56FA0Q55069818-0B2D7A2E-BBC5-4632-93D8-E43C9725A68FQ57789726-96B165DB-A9E0-46B4-9C83-783DE0D1CE13Q58581542-7AFAE191-4FC3-4E72-94A2-FC3333A0F776Q87000069-822C092A-1FD3-46A3-854A-7076CB09D50BQ89417771-9EBC6E09-199E-4B18-BF50-43FA4AE2999DQ90164029-3BA3BFE0-42CE-41B4-B833-E3476091AE0E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ryan Lillico
@ast
Ryan Lillico
@en
Ryan Lillico
@es
Ryan Lillico
@nl
Ryan Lillico
@sl
type
label
Ryan Lillico
@ast
Ryan Lillico
@en
Ryan Lillico
@es
Ryan Lillico
@nl
Ryan Lillico
@sl
prefLabel
Ryan Lillico
@ast
Ryan Lillico
@en
Ryan Lillico
@es
Ryan Lillico
@nl
Ryan Lillico
@sl
P106
P1153
57053288400
P21
P31
P496
0000-0002-9486-9254